AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 35,000 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 11, 2026 · Filed Nov 13, 2026

On Nov 11, 2026, Equels Thomas K (Director, CEO & President) bought 35,000 AIM ImmunoTech Inc. shares at US$0.15 for US$5,215, leaving 328,095 shares. Filed Nov 13, 2026 (Form 4).

Bought
35,000 shares
Price
US$0.15
Value
US$5,215
Holding after
328,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 11, 2026Common StockBuy35,000US$0.15328,095Direct

Source

Download original · View original at SEC

Related